PAB40590 TNK2 Polyclonal Antibody | 北京灵宝科技有限公司,委托生产,技术转让,生产工艺CDMO,OEM,ODM,CRO,CMO,菌珠构建,化药合成工艺转让;新药证书转让;临床批件转让;CRA;CRC

产品中心

Combined inhibition of ACK1 and AKT shows potential toward targeted therapy against KRAS-mutant non-small-cell lung cancer